The director-general of the national pharmacovigilance centre and member of the scientific committee for the fight against the coronavirus Riadh Daghfous declared that a pharmaceutical company that produces the drug against Covid-19 has expressed its willingness to sign a sub-agreement license with Tunisia to manufacture the-covid treatment.
“Nevertheless, this drug can only be produced in Tunisia if we guarantee that it is effective”, remarked the member of the Scientific Committee on a private radio station, emphasising that once manufactured in Tunisia, the pill will be sold at affordable prices
What's happening in Tunisia?
Subscribe to our Youtube channel for updates.
